Sepio Capital
ABBV icon

Sepio Capital’s AbbVie ABBV Stock Holding History

Sepio Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$196M Buy
749,451
+619,274
+476% +$159M 7.83% 2
2026
Q2 		$32.8M Sell
130,177
-6,551
-5% -$1.41M 1.65% 6
2026
Q1 		$29.7M Buy
136,728
+10,813
+9% +$2.4M 1.61% 7
2025
Q4 		$28.8M Sell
125,915
-9,074
-7% -$2.07M 1.57% 10
2025
Q3 		$31.3M Sell
134,989
-74,746
-36% -$15.2M 1.85% 8
2025
Q2 		$38.9M Sell
209,735
-19,432
-8% -$3.61M 2.77% 5
2025
Q1 		$48M Buy
229,167
+61,794
+37% +$12M 3.8% 4
2024
Q4 		$29.7M Sell
167,373
-38,086
-19% -$7M 2.38% 6
2024
Q3 		$40.6M Buy
205,459
+72,207
+54% +$13.5M 3.16% 4
2024
Q2 		$22.9M Sell
133,252
-27,995
-17% -$4.64M 2.1% 7
2024
Q1 		$29.4M Sell
161,247
-1,544
-0.9% -$266K 2.52% 5
2023
Q4 		$25.2M Sell
162,791
-17,328
-10% -$2.53M 2.12% 6
2023
Q3 		$26.8M Sell
180,119
-23,033
-11% -$3.38M 2.32% 5
2023
Q2 		$27.4M Buy
203,152
+42,715
+27% +$6.26M 2.22% 4
2023
Q1 		$25.6M Sell
160,437
-37,732
-19% -$5.77M 2.36% 3
2022
Q4 		$32M Sell
198,169
-31,522
-14% -$4.83M 2.77% 5
2022
Q3 		$30.8M Buy
229,691
+128,412
+127% +$18.4M 3.06% 5
2022
Q2 		$15.5M Buy
101,279
+77,950
+334% +$11.9M 1.56% 8
2022
Q1 		$3.78M Sell
23,329
-3,895
-14% -$566K 0.33% 93
2021
Q4 		$3.69M Buy
+27,224
New +$3.22M 0.27% 110
2019
Q1 		– Sell
-1,371,271
Closed -$126M – 218
2018
Q4 		$126M Buy
+1,371,271
New +$121M 9.19% 2

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Sepio Capital's ABBV Position: Q3 2026 in Review

Sepio Capital increased its AbbVie (ABBV) stake by 476% in Q3 2026, buying an estimated $159M and bringing the position to 749,451 shares worth $196M. The position accounts for 7.83% of the portfolio, ranked #2.

Sepio Capital first reported a position in ABBV in Q4 2018 and has held it in 21 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Sepio Capital held 749,451 shares of AbbVie worth $196M as of Q3 2026.
  • Sepio Capital bought 619,274 AbbVie shares in Q3 2026, an estimated $159M.
  • AbbVie made up 7.83% of Sepio Capital's portfolio in Q3 2026, its #2 holding.
  • Sepio Capital first reported a position in AbbVie in Q4 2018 and has held it in 21 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Sepio Capital's 13F filing for Q3 2026, filed 22 Oct 2026.